Search

Your search keyword '"Sakashita, T"' showing total 399 results

Search Constraints

Start Over You searched for: Author "Sakashita, T" Remove constraint Author: "Sakashita, T"
399 results on '"Sakashita, T"'

Search Results

101. Indications for sentinel lymph node biopsy in node-negative oral cancers.

102. A case of coexistent poorly differentiated adenosquamous carcinoma (glassy cell carcinoma), usual-type adenocarcinoma, and squamous cell carcinoma in situ of the cervix.

105. An exa-scale high-performance molecular dynamics simulation program: MODYLAS.

106. Clustering of charged colloidal particles in the microgravity environment of space.

107. Applicability of on-site disinfection of personal protective equipment by ozone gas.

108. Comparison of the loci associated with HbA1c and blood glucose levels identified by a genome-wide association study in the Japanese population.

109. Comparative evaluation of radionuclide therapy using 90 Y and 177 Lu.

110. Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.

111. Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[ 211 At]astato-benzylguanidine.

112. Suicide Prevention Interventions and Their Linkages in Multilayered Approaches for Older Adults: A Review and Comparison.

113. Predictive factors for false negatives following sentinel lymph node biopsy in early oral cavity cancer.

114. Point Prevalence Surveys of Antimicrobial Prescribing in a Non-Acute Care Hospital in Saitama Prefecture, Japan.

115. Nonclinical study and applicability of the absorbed dose conversion method with a single biodistribution measurement for targeted alpha-nuclide therapy.

116. High-Dose Irradiation Inhibits Motility and Induces Autophagy in Caenorhabditis elegans .

117. Pathological evidence of demyelination in the recurrent laryngeal, phrenic, and oculomotor nerves in Charcot-Marie-Tooth disease 4F.

118. Algorithm to minimize MPI communications in the parallelized fast multipole method combined with molecular dynamics calculations.

119. RNA sequencing data for gamma radiation response in the extremotolerant tardigrade Ramazzottius varieornatus .

120. Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis.

122. Absorbed dose simulation of meta- 211 At-astato-benzylguanidine using pharmacokinetics of 131 I-MIBG and a novel dose conversion method, RAP.

123. Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment.

124. A case of immune thrombocytopenia due to miliary tuberculosis effectively treated with eltrombopag.

125. Pathological evaluation of the accuracy of a fluorescence spectroscopy system for detecting parathyroid glands.

126. A novel study for fluorescence patterns of the parathyroid glands during surgery using a fluorescence spectroscopy system.

127. Uremic serum residue decreases SN-38 sensitivity through suppression of organic anion transporter polypeptide 2B1 in LS-180 colon cancer cells.

129. A biologically based mathematical model for spontaneous and ionizing radiation cataractogenesis.

130. Developing a Hypothetical Model for Suicide Progression in Older Adults With Universal, Selective, and Indicated Prevention Strategies.

131. Immobilization of Live Caenorhabditis elegans Individuals Using an Ultra-thin Polydimethylsiloxane Microfluidic Chip with Water Retention.

132. Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance.

133. Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta - 211 At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing.

134. Comparison of the University of Pittsburgh staging system and the eighth edition of the American Joint Committee on Cancer TNM classification for the prognostic evaluation of external auditory canal cancer.

135. Validation of the 8th edition of the AJCC/UICC TNM staging system for tongue squamous cell carcinoma.

136. Anti-mumps IgM antibody positive rate with sudden sensorineural hearing loss using second-generation enzyme immunoassay: A retrospective, multi-institutional investigation in Hokkaido, Japan.

137. Development of ultra-thin chips for immobilization of Caenorhabditis elegans in microfluidic channels during irradiation and selection of buffer solution to prevent dehydration.

138. Antitumor effects of radionuclide treatment using α-emitting meta- 211 At-astato-benzylguanidine in a PC12 pheochromocytoma model.

139. Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.

140. Rational evaluation of the therapeutic effect and dosimetry of auger electrons for radionuclide therapy in a cell culture model.

141. Utility of a Hybrid IVIM-DKI Model to Predict the Development of Distant Metastasis in Head and Neck Squamous Cell Carcinoma Patients.

142. Region-specific irradiation system with heavy-ion microbeam for active individuals of Caenorhabditis elegans.

143. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.

144. Osteoradionecrosis of the hyoid bone after intra-arterial chemoradiotherapy for oropharyngeal cancer: MR imaging findings.

145. Role of microRNA-296-3p in the malignant transformation of sinonasal inverted papilloma.

146. Non-invasive prediction of the tumor growth rate using advanced diffusion models in head and neck squamous cell carcinoma patients.

147. Residual tumour detection in post-treatment granulation tissue by using advanced diffusion models in head and neck squamous cell carcinoma patients.

148. Demeanor of rivaroxaban in activated/inactivated FXa.

149. Prediction of the treatment outcome using intravoxel incoherent motion and diffusional kurtosis imaging in nasal or sinonasal squamous cell carcinoma patients.

150. Advanced diffusion models in head and neck squamous cell carcinoma patients: Goodness of fit, relationships among diffusion parameters and comparison with dynamic contrast-enhanced perfusion.

Catalog

Books, media, physical & digital resources